Hospital
Mercy Medical Center INC
Mercy Medical Center INC was paid $6.04M by Medicaid between Jan 2018 and Dec 2024, across 166 billing codes. Its largest line is G0378, Hospital observation service, per hour — 20% of everything it billed.
33Billing provider infoMERCY MEDICAL CENTER INC
BALTIMORE, MD 21202
BALTIMORE, MD 21202
33aNPI1144282583assigned 04/03/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$6.04M
24GClaims217,610
24DCodes billed166
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Maryland
Rank by total paid#7 of 69
Median peer was paid$870K
This provider vs. median6.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official DEIBEL, JUSTIN controls 19+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 35,728 | $1.42M | |
| 2019 | 34,098 | $1.32M | |
| 2020 | 23,577 | $622K | |
| 2021 | 33,151 | $744K | |
| 2022 | 36,711 | $754K | |
| 2023 | 34,414 | $698K | |
| 2024incomplete | 19,931 | $473K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0378 | Hospital observation service, per hour | 20% | 1,880 | 1,706 | $1.22M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 17% | 6,047 | 5,350 | $1.05M |
| 41899 | Unlisted procedure, dentoalveolar structures | 16% | 169 | 158 | $988K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 14% | 8,197 | 6,898 | $816K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.6% | 2,683 | 2,394 | $581K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 4.7% | 8,237 | 6,267 | $286K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.9% | 3,819 | 3,002 | $237K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 3.7% | 29,235 | 24,822 | $221K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.6% | 1,246 | 1,199 | $95K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 3,053 | 937 | $56K |
| 20610 | <1% | 1,489 | 1,289 | $55K | |
| 94010 | <1% | 642 | 628 | $51K |
154 more codes
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 402 | $47K |
| 73562 | <1% | 1,538 | $43K | |
| 97161 | <1% | 767 | $30K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 165 | $25K |
| 93971 | <1% | 339 | $22K | |
| 93923 | <1% | 529 | $17K | |
| 73630 | <1% | 1,078 | $16K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 240 | $15K |
| 62323 | <1% | 168 | $15K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 255 | $14K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,637 | $14K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 2,231 | $12K |
| 84484 | <1% | 2,634 | $10K | |
| 72110 | <1% | 186 | $10K | |
| 71250 | <1% | 157 | $9K | |
| 82962 | <1% | 8,937 | $8K | |
| 36591 | <1% | 213 | $8K | |
| 93970 | <1% | 69 | $7K | |
| C8929 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography | <1% | 300 | $6K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 102 | $6K |
| 73030 | <1% | 444 | $5K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,985 | $5K |
| 73610 | <1% | 84 | $4K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 141 | $4K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 5,789 | $4K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,074 | $4K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 908 | $3K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 50 | $3K |
| 97165 | <1% | 346 | $3K | |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | <1% | 80 | $3K |
| 72100 | <1% | 91 | $2K | |
| 81001 | <1% | 2,681 | $2K | |
| 80053 | Comprehensive metabolic panel | <1% | 10,772 | $2K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,332 | $2K |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 1,229 | $1K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 201 | $913.22 |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 237 | $800.29 |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 190 | $782.32 |
| 85610 | <1% | 3,327 | $766.68 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 11,507 | $739.23 |
| 83880 | <1% | 204 | $724.92 | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 218 | $709.54 |
| 71045 | Radiologic examination, chest; single view | <1% | 1,811 | $641.04 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,396 | $537.88 |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 18 | $512.92 |
| 76642 | <1% | 52 | $476.88 | |
| 73502 | <1% | 55 | $470.36 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 31 | $429.20 |
| 86803 | <1% | 1,448 | $347.02 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 469 | $300.15 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 590 | $293.11 |
| 84703 | <1% | 885 | $269.01 | |
| 85730 | <1% | 2,012 | $268.57 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,909 | $254.84 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 38 | $252.86 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 38 | $237.84 |
| 94729 | <1% | 323 | $223.42 | |
| 80061 | Lipid panel | <1% | 577 | $222.36 |
| 88142 | <1% | 14 | $209.06 | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 128 | $187.32 |
| 73130 | <1% | 28 | $187.14 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 1,680 | $174.05 |
| 82553 | <1% | 290 | $168.60 | |
| 83540 | <1% | 2,459 | $162.48 | |
| 97116 | <1% | 20 | $160.50 | |
| 94727 | <1% | 377 | $131.45 | |
| 82728 | <1% | 1,214 | $126.47 | |
| 83735 | <1% | 7,385 | $123.81 | |
| 83874 | <1% | 241 | $122.78 | |
| 87522 | Neg quan hep c or qual rna | <1% | 14 | $110.10 |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 1,366 | $108.47 |
| 83690 | <1% | 1,097 | $105.43 | |
| 86850 | <1% | 1,392 | $103.36 | |
| 80076 | <1% | 471 | $100.00 | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 12 | $94.76 |
| 82550 | <1% | 354 | $84.61 | |
| 85027 | <1% | 5,184 | $83.41 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,301 | $71.54 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 40 | $68.50 |
| 81003 | <1% | 734 | $67.84 | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 14 | $56.49 |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 83 | $42.56 |
| 87400 | <1% | 288 | $42.08 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 9,042 | $35.37 |
| 83550 | <1% | 2,319 | $33.95 | |
| 76000 | <1% | 291 | $29.26 | |
| 82378 | <1% | 56 | $28.42 | |
| 93017 | <1% | 12 | $28.10 | |
| 86900 | <1% | 1,407 | $20.62 | |
| 86901 | <1% | 1,396 | $17.34 | |
| 82150 | <1% | 219 | $16.95 | |
| 84100 | <1% | 1,744 | $15.08 | |
| 87340 | <1% | 548 | $14.17 | |
| 81015 | <1% | 52 | $13.07 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,052 | $12.41 |
| J2704 | Injection, propofol, 10 mg | <1% | 5,913 | $8.68 |
| 86140 | <1% | 65 | $3.00 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 5,212 | $2.25 |
| 84439 | <1% | 85 | $0.60 | |
| 87641 | <1% | 38 | $0.56 | |
| 88342 | 0% | 413 | $0.00 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 0% | 805 | $0.00 |
| 85379 | 0% | 14 | $0.00 | |
| J1815 | Injection, insulin, per 5 units | 0% | 230 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 18 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 97 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 665 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 415 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 2,673 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 621 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 3,033 | $0.00 |
| 85652 | 0% | 124 | $0.00 | |
| 82746 | 0% | 56 | $0.00 | |
| 73600 | 0% | 40 | $0.00 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 0% | 277 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 469 | $0.00 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 0% | 106 | $0.00 |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 0% | 29 | $0.00 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 0% | 66 | $0.00 |
| 76820 | 0% | 14 | $0.00 | |
| 82607 | 0% | 118 | $0.00 | |
| 83605 | 0% | 15 | $0.00 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 23 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 0% | 28 | $0.00 |
| 83615 | 0% | 13 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 49 | $0.00 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 0% | 13 | $0.00 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 0% | 13 | $0.00 |
| J2785 | Injection, regadenoson, 0.1 mg | 0% | 12 | $0.00 |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 0% | 12 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 13 | $0.00 |
| 87077 | 0% | 13 | $0.00 | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 0% | 111 | $0.00 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 44 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 592 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 717 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 209 | $0.00 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 236 | $0.00 |
| 81002 | 0% | 520 | $0.00 | |
| J3370 | Injection, vancomycin hcl, 500 mg | 0% | 60 | $0.00 |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 0% | 117 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 284 | $0.00 |
| 96367 | 0% | 22 | $0.00 | |
| 84520 | 0% | 13 | $0.00 | |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 197 | $0.00 |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 0% | 35 | $0.00 |
| 82565 | 0% | 13 | $0.00 | |
| 88312 | 0% | 27 | $0.00 | |
| 84165 | 0% | 13 | $0.00 | |
| 85007 | 0% | 27 | $0.00 | |
| J3371 | Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mg | 0% | 19 | $0.00 |
| 87186 | 0% | 14 | $0.00 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 17 | $0.00 |
| A9576 | Injection, gadoteridol, (prohance multipack), per ml | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDEIBEL, JUSTIN (CHIEF FINANCIAL OFFICER)
| Provider | Location | Paid |
|---|---|---|
| ST Paul Place Specialists, INC. | Baltimore, MD | $13.35M |
| Emergency Physicians SPPS | Baltimore, MD | $9.82M |
| Saint Paul Place Specialists, INC. | Baltimore, MD | $1.51M |
| ST Paul Place Specialists, INC. | Baltimore, MD | $1.49M |
| ST Paul Place Specialists INC | Baltimore, MD | $1.42M |
| ST Paul Place Specialists, INC. | Baltimore, MD | $1.34M |
| ST Paul Place Specialists, INC. | Baltimore, MD | $1.15M |
| ST Paul Place Specialists, INC. | Baltimore, MD | $949K |
| Saint Paul Place Specialists, INC. | Baltimore, MD | $428K |
| Vascular Specialty Services, LLC | Baltimore, MD | $397K |
| Saint Paul Place Specialists, INC. | Baltimore, MD | $179K |
| ST. Paul Place Specialists, INC. | Baltimore, MD | $177K |
| ST Paul Place Specialists, INC. | Baltimore, MD | $138K |
| ST. Paul Place Specialists, INC. | Baltimore, MD | $8K |
| ST Paul Place Specialists, INC. | Baltimore, MD | $6K |
| Saint Paul Place Specialists, INC. | Baltimore, MD | $4K |
| Saint Paul Place Specialists, INC. | Baltimore, MD | $4K |
| ST. Paul Place Specialists, INC. | Baltimore, MD | $1K |
| ST. Paul Place Specialists, INC. | Baltimore, MD | $77.13 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.